Bank Julius Baer & Co
AMED

Bank Julius Baer & Co’s Amedisys AMED Stock Holding History

Bank Julius Baer & Co’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-327
Closed -$24K – 560
2023
Q1 		$24K Sell
327
-783
-71% -$67.7K ﹤0.01% 542
2022
Q4 		$93K Sell
1,110
-10
-0.9% -$902 ﹤0.01% 480
2022
Q3 		$108K Sell
1,120
-31,638
-97% -$3.77M ﹤0.01% 454
2022
Q2 		$3.44M Buy
32,758
+1,758
+6% +$225K 0.02% 185
2022
Q1 		$5.34M Sell
31,000
-1,454
-4% -$217K 0.03% 169
2021
Q4 		$5.25M Buy
32,454
+2,907
+10% +$467K 0.03% 198
2021
Q3 		$4.41M Buy
29,547
+5,695
+24% +$1.18M 0.03% 203
2021
Q2 		$5.84M Buy
23,852
+7,038
+42% +$1.85M 0.04% 208
2021
Q1 		$4.45M Buy
16,814
+8,693
+107% +$2.45M 0.03% 206
2020
Q4 		$2.38M Buy
8,121
+1,392
+21% +$357K 0.02% 249
2020
Q3 		$1.59M Buy
6,729
+688
+11% +$156K 0.02% 249
2020
Q2 		$1.2M Sell
6,041
-233
-4% -$43.5K 0.01% 249
2020
Q1 		$1.15M Buy
+6,274
New +$1.12M 0.03% 206

Other funds holding AMED

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

Bank Julius Baer & Co's AMED Position: Q2 2023 in Review

Bank Julius Baer & Co sold out of Amedisys (AMED) in Q2 2023, closing a stake of 327 shares — an estimated $24K sold.

Bank Julius Baer & Co first reported a position in AMED in Q1 2020 and held it in 13 quarters. The position peaked at $5.84M in Q2 2021. 301 funds tracked by Wall St. Rank hold AMED as of Q2 2023.

  • Bank Julius Baer & Co reported no remaining Amedisys position as of Q2 2023 after selling out during the quarter.
  • Bank Julius Baer & Co sold 327 Amedisys shares in Q2 2023, an estimated $24K.
  • Bank Julius Baer & Co first reported a position in Amedisys in Q1 2020 and held it in 13 quarters.
  • Bank Julius Baer & Co's Amedisys position peaked at $5.84M in Q2 2021.
  • 301 funds tracked by Wall St. Rank held Amedisys as of Q2 2023.

Based on Bank Julius Baer & Co's 13F filing for Q2 2023, filed 20 Jul 2023.